Etoposide is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Accord Healthcare Inc.. The primary component is Etoposide.
| Product ID | 16729-262_5b5fc65e-1c07-c059-e053-2991aa0ac3ce |
| NDC | 16729-262 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Etoposide |
| Generic Name | Etoposide |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2013-08-22 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA074513 |
| Labeler Name | Accord Healthcare Inc. |
| Substance Name | ETOPOSIDE |
| Active Ingredient Strength | 20 mg/mL |
| Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2013-08-22 |
| Marketing End Date | 2021-10-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA074513 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-01-01 |
| Marketing Category | ANDA |
| Application Number | ANDA074513 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2013-08-22 |
| Ingredient | Strength |
|---|---|
| ETOPOSIDE | 20 mg/mL |
| SPL SET ID: | 003ce7e0-f787-469d-8b44-3c2acdcae6d7 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9376 | Etoposide | Etoposide |
| 0143-9510 | Etoposide | Etoposide |
| 0143-9511 | Etoposide | Etoposide |
| 0143-9512 | Etoposide | Etoposide |
| 0378-3266 | Etoposide | etoposide |
| 16729-114 | Etoposide | Etoposide |
| 16729-262 | Etoposide | Etoposide |
| 63323-104 | Etoposide | ETOPOSIDE |
| 68001-265 | Etoposide | Etoposide |
| 0703-5653 | Toposar | Etoposide |
| 0703-5656 | Toposar | Etoposide |
| 0703-5657 | Toposar | Etoposide |